Tunisia
Review Article
Serous and Mucinous Borderline Ovarian Tumours: Evaluation of Clinical Outcome and Risk Factors for Recurrence
Author(s): Nesrine Tounsi, Hatem Bouzaine, Raoudha Doghri, Maher Slimane, Jamel Ben Hassouna and Khaled RahelNesrine Tounsi, Hatem Bouzaine, Raoudha Doghri, Maher Slimane, Jamel Ben Hassouna and Khaled Rahel
Objective: Borderline Ovarian Tumors (BOTs) have a good prognosis; however, a few BOT patients experience the relapse of disease, either borderline or malignant. The aims of this study were to analyze the risk factors of relapse.
Methods: This is a retrospective study of 31 patients with confirmed BOTs treated in the Salah Azaiez Oncologic institute between 2005 and 2015.
Results: 31 cases were identified; median age was 43 years. Most of the patients 27 (87%) demonstrated stage IA. 8 patients had laparoscopic surgery and they were all treated conservatively. Between 23 patients, which had laparotomy, only two cases underwent conservative surgery and the remaining patients had radical surgery. Five patients had recurrences (16.13%). The relapse was occurred meanly 62.38 months after the primary surgery. Among the 5.. Read More»
DOI:
10.4172/1948-5956.1000495
Cancer Science & Therapy received 5282 citations as per Google Scholar report